Listed

LifeStance Health Group, Inc.

LFSTNasdaqCIK 1845257HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$435.4m, Q2 FY2026
Operating income$30.7m, Q2 FY2026
Net income$23.6m, Q2 FY2026
LifeStance Health Group, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m263Revenue, Q3 FY2023, three months to 2023-09-30$262.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure281Revenue, Q4 FY2023, three months to 2023-12-31$280.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure300Revenue, Q1 FY2024, three months to 2024-03-31$300.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure312Revenue, Q2 FY2024, three months to 2024-06-30$312.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure313Revenue, Q3 FY2024, three months to 2024-09-30$312.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure325Revenue, Q4 FY2024, three months to 2024-12-31$325.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure333Revenue, Q1 FY2025, three months to 2025-03-31$333.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure345Revenue, Q2 FY2025, three months to 2025-06-30$345.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure364Revenue, Q3 FY2025, three months to 2025-09-30$363.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure382Revenue, Q4 FY2025, three months to 2025-12-31$382.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure403Revenue, Q1 FY2026, three months to 2026-03-31$403.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure435Revenue, Q2 FY2026, three months to 2026-06-30$435.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Selling, general and administrative$m131Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$130.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure93.4Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$93.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure88.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$88.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure95.2Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$95.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure85.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$85.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure93.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$93.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure94.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$94.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure97.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$97.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure95.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$95.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure94.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$94.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure100Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$100.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure108Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$108.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Operating income$m(74.4)Operating income, Q3 FY2023, three months to 2023-09-30−$74.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure(32.3)Operating income, Q4 FY2023, three months to 2023-12-31−$32.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Operating income, Q1 FY2024, three months to 2024-03-31−$16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure(15.9)Operating income, Q2 FY2024, three months to 2024-06-30−$15.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure0.0Operating income, Q3 FY2024, three months to 2024-09-30$47.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure1.1Operating income, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure1.6Operating income, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure(3.0)Operating income, Q2 FY2025, three months to 2025-06-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure7.4Operating income, Q3 FY2025, three months to 2025-09-30$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure18.1Operating income, Q4 FY2025, three months to 2025-12-31$18.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure22.3Operating income, Q1 FY2026, three months to 2026-03-31$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure30.7Operating income, Q2 FY2026, three months to 2026-06-30$30.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Interest expense$m5.5Interest expense, Q3 FY2023, three months to 2023-09-30$5.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure5.5Interest expense, Q4 FY2023, three months to 2023-12-31$5.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure5.9Interest expense, Q1 FY2024, three months to 2024-03-31$5.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure5.8Interest expense, Q2 FY2024, three months to 2024-06-30$5.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure5.4Interest expense, Q3 FY2024, three months to 2024-09-30$5.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure9.4Interest expense, Q4 FY2024, three months to 2024-12-31$9.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure3.1Interest expense, Q1 FY2025, three months to 2025-03-31$3.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure2.9Interest expense, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure2.8Interest expense, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure2.9Interest expense, Q4 FY2025, three months to 2025-12-31$2.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure1.8Interest expense, Q1 FY2026, three months to 2026-03-31$1.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure2.6Interest expense, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Income tax$m(16.4)Income tax, Q3 FY2023, three months to 2023-09-30−$16.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure6.6Income tax, Q4 FY2023, three months to 2023-12-31$6.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2024, three months to 2024-03-31$363.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure0.7Income tax, Q2 FY2024, three months to 2024-06-30$656.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure0.6Income tax, Q3 FY2024, three months to 2024-09-30$575.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure(1.8)Income tax, Q4 FY2024, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Income tax, Q1 FY2025, three months to 2025-03-31−$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure(2.2)Income tax, Q2 FY2025, three months to 2025-06-30−$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure3.5Income tax, Q3 FY2025, three months to 2025-09-30$3.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure3.5Income tax, Q4 FY2025, three months to 2025-12-31$3.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure5.5Income tax, Q1 FY2026, three months to 2026-03-31$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure3.8Income tax, Q2 FY2026, three months to 2026-06-30$3.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Net income$m(61.6)Net income, Q3 FY2023, three months to 2023-09-30−$61.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure(45.0)Net income, Q4 FY2023, three months to 2023-12-31−$45.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure(21.1)Net income, Q1 FY2024, three months to 2024-03-31−$21.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure(23.3)Net income, Q2 FY2024, three months to 2024-06-30−$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure0.7Net income, Q3 FY2024, three months to 2024-09-30$709.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure(7.1)Net income, Q4 FY2024, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure0.7Net income, Q1 FY2025, three months to 2025-03-31$709.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure(3.8)Net income, Q2 FY2025, three months to 2025-06-30−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure1.1Net income, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure11.7Net income, Q4 FY2025, three months to 2025-12-31$11.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure14.2Net income, Q1 FY2026, three months to 2026-03-31$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure23.6Net income, Q2 FY2026, three months to 2026-06-30$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure

Balance sheet

Cash and equivalents$225.9m, Q2 FY2026
Long-term debt$259.0m, Q2 FY2026
Shareholders' equity$1.48bn, Q2 FY2026
LifeStance Health Group, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m42.6Cash and equivalents, Q3 FY2023, at 2023-09-30$42.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure78.8Cash and equivalents, FY2023, at 2023-12-31$78.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure49.5Cash and equivalents, Q1 FY2024, at 2024-03-31$49.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure87.0Cash and equivalents, Q2 FY2024, at 2024-06-30$87.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure103Cash and equivalents, Q3 FY2024, at 2024-09-30$102.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure155Cash and equivalents, FY2024, at 2024-12-31$154.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure134Cash and equivalents, Q1 FY2025, at 2025-03-31$134.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure189Cash and equivalents, Q2 FY2025, at 2025-06-30$188.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure204Cash and equivalents, Q3 FY2025, at 2025-09-30$203.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure249Cash and equivalents, FY2025, at 2025-12-31$248.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure195Cash and equivalents, Q1 FY2026, at 2026-03-31$194.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure226Cash and equivalents, Q2 FY2026, at 2026-06-30$225.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Current assets$m264Current assets, Q3 FY2023, at 2023-09-30$264.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure226Current assets, FY2023, at 2023-12-31$225.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure244Current assets, Q1 FY2024, at 2024-03-31$244.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure278Current assets, Q2 FY2024, at 2024-06-30$277.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure287Current assets, Q3 FY2024, at 2024-09-30$287.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure313Current assets, FY2024, at 2024-12-31$312.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure305Current assets, Q1 FY2025, at 2025-03-31$304.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure359Current assets, Q2 FY2025, at 2025-06-30$358.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure360Current assets, Q3 FY2025, at 2025-09-30$360.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure416Current assets, FY2025, at 2025-12-31$416.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure356Current assets, Q1 FY2026, at 2026-03-31$355.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure378Current assets, Q2 FY2026, at 2026-06-30$378.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Total assets$m2,175Total assets, Q3 FY2023, at 2023-09-30$2.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure2,110Total assets, FY2023, at 2023-12-31$2.11bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure2,106Total assets, Q1 FY2024, at 2024-03-31$2.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure2,119Total assets, Q2 FY2024, at 2024-06-30$2.12bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure2,108Total assets, Q3 FY2024, at 2024-09-30$2.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure2,118Total assets, FY2024, at 2024-12-31$2.12bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure2,105Total assets, Q1 FY2025, at 2025-03-31$2.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure2,147Total assets, Q2 FY2025, at 2025-06-30$2.15bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure2,149Total assets, Q3 FY2025, at 2025-09-30$2.15bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure2,204Total assets, FY2025, at 2025-12-31$2.20bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure2,146Total assets, Q1 FY2026, at 2026-03-31$2.15bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure2,181Total assets, Q2 FY2026, at 2026-06-30$2.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Current liabilities$m241Current liabilities, Q3 FY2023, at 2023-09-30$240.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure203Current liabilities, FY2023, at 2023-12-31$202.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure207Current liabilities, Q1 FY2024, at 2024-03-31$207.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure228Current liabilities, Q2 FY2024, at 2024-06-30$227.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure218Current liabilities, Q3 FY2024, at 2024-09-30$217.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure229Current liabilities, FY2024, at 2024-12-31$228.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure207Current liabilities, Q1 FY2025, at 2025-03-31$207.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure242Current liabilities, Q2 FY2025, at 2025-06-30$242.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure229Current liabilities, Q3 FY2025, at 2025-09-30$228.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure252Current liabilities, FY2025, at 2025-12-31$252.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure240Current liabilities, Q1 FY2026, at 2026-03-31$239.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure275Current liabilities, Q2 FY2026, at 2026-06-30$274.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Total liabilities$m720Total liabilities, Q3 FY2023, at 2023-09-30$720.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure681Total liabilities, FY2023, at 2023-12-31$681.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure677Total liabilities, Q1 FY2024, at 2024-03-31$677.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure689Total liabilities, Q2 FY2024, at 2024-06-30$689.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure671Total liabilities, Q3 FY2024, at 2024-09-30$670.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure672Total liabilities, FY2024, at 2024-12-31$672.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure648Total liabilities, Q1 FY2025, at 2025-03-31$647.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure673Total liabilities, Q2 FY2025, at 2025-06-30$672.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure656Total liabilities, Q3 FY2025, at 2025-09-30$656.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure683Total liabilities, FY2025, at 2025-12-31$682.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure668Total liabilities, Q1 FY2026, at 2026-03-31$668.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure704Total liabilities, Q2 FY2026, at 2026-06-30$704.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Long-term debt$m248Long-term debt, Q3 FY2023, at 2023-09-30$248.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure280Long-term debt, FY2023, at 2023-12-31$280.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure280Long-term debt, Q1 FY2024, at 2024-03-31$279.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure279Long-term debt, Q2 FY2024, at 2024-06-30$279.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure279Long-term debt, Q3 FY2024, at 2024-09-30$279.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure280Long-term debt, FY2024, at 2024-12-31$279.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure276Long-term debt, Q1 FY2025, at 2025-03-31$276.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure273Long-term debt, Q2 FY2025, at 2025-06-30$272.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure269Long-term debt, Q3 FY2025, at 2025-09-30$269.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure266Long-term debt, FY2025, at 2025-12-31$265.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure262Long-term debt, Q1 FY2026, at 2026-03-31$262.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure259Long-term debt, Q2 FY2026, at 2026-06-30$259.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Current portion of debt$m2.6Current portion of debt, Q3 FY2023, at 2023-09-30$2.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure2.9Current portion of debt, FY2023, at 2023-12-31$2.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure2.9Current portion of debt, Q1 FY2024, at 2024-03-31$2.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure2.9Current portion of debt, Q2 FY2024, at 2024-06-30$2.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure2.9Current portion of debt, Q3 FY2024, at 2024-09-30$2.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure7.3Current portion of debt, FY2024, at 2024-12-31$7.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure9.1Current portion of debt, Q1 FY2025, at 2025-03-31$9.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure10.9Current portion of debt, Q2 FY2025, at 2025-06-30$10.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure12.7Current portion of debt, Q3 FY2025, at 2025-09-30$12.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure14.5Current portion of debt, FY2025, at 2025-12-31$14.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure18.1Current portion of debt, Q1 FY2026, at 2026-03-31$18.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure14.5Current portion of debt, Q2 FY2026, at 2026-06-30$14.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure
Shareholders' equity$m1,455Shareholders' equity, Q3 FY2023, at 2023-09-30$1.46bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure1,429Shareholders' equity, FY2023, at 2023-12-31$1.43bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-27, accession 0000950170-25-029100.Report this figure1,429Shareholders' equity, Q1 FY2024, at 2024-03-31$1.43bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure1,430Shareholders' equity, Q2 FY2024, at 2024-06-30$1.43bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure1,437Shareholders' equity, Q3 FY2024, at 2024-09-30$1.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure1,446Shareholders' equity, FY2024, at 2024-12-31$1.45bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001193125-26-071462.Report this figure1,457Shareholders' equity, Q1 FY2025, at 2025-03-31$1.46bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure1,474Shareholders' equity, Q2 FY2025, at 2025-06-30$1.47bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure1,493Shareholders' equity, Q3 FY2025, at 2025-09-30$1.49bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure1,521Shareholders' equity, FY2025, at 2025-12-31$1.52bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure1,477Shareholders' equity, Q1 FY2026, at 2026-03-31$1.48bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure1,477Shareholders' equity, Q2 FY2026, at 2026-06-30$1.48bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure

Cash flow

Operating cash flow$99.9m, Q2 FY2026
Capital expenditure$12.0m, Q2 FY2026
Share repurchases$48.5m, Q2 FY2026
LifeStance Health Group, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(25.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123376. Derived: 9-month figure less the 6-month figure.Report this figure16.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure(21.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure44.1Operating cash flow, Q2 FY2024, three months to 2024-06-30$44.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105096. Derived: 6-month figure less the 3-month figure.Report this figure22.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269712. Derived: 9-month figure less the 6-month figure.Report this figure62.3Operating cash flow, Q4 FY2024, three months to 2024-12-31$62.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure64.4Operating cash flow, Q2 FY2025, three months to 2025-06-30$64.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338107. Derived: 6-month figure less the 3-month figure.Report this figure27.3Operating cash flow, Q3 FY2025, three months to 2025-09-30$27.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269712. Derived: 9-month figure less the 6-month figure.Report this figure57.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$57.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure33.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$33.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure99.9Operating cash flow, Q2 FY2026, three months to 2026-06-30$99.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338107. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m9.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$9.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123376. Derived: 9-month figure less the 6-month figure.Report this figure11.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$11.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure5.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure5.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105096. Derived: 6-month figure less the 3-month figure.Report this figure5.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269712. Derived: 9-month figure less the 6-month figure.Report this figure6.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$6.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure7.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$7.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure7.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$7.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338107. Derived: 6-month figure less the 3-month figure.Report this figure10.3Capital expenditure, Q3 FY2025, three months to 2025-09-30$10.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269712. Derived: 9-month figure less the 6-month figure.Report this figure10.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001193125-26-071462. Derived: 12-month figure less the 9-month figure.Report this figure10.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$10.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure12.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$12.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338107. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001193125-26-338107. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported49.1Share repurchases, Q1 FY2026, three months to 2026-03-31$49.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure48.5Share repurchases, Q2 FY2026, three months to 2026-06-30$48.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001193125-26-338107. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)387.30m, Q2 FY2026
LifeStance Health Group, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30357,520 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061118.Report this figure361Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31360,902,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056989.Report this figure363Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30363,161,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094105.Report this figure372Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30372,476,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123376.Report this figure376Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31376,331,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065806.Report this figure379Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30379,427,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105096.Report this figure380Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30380,359,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure391Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31390,666,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure387Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30386,733,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure389Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30388,895,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269712.Report this figure395Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31395,084,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211814.Report this figure387Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30387,299,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure

Shares outstanding: 382.06mShares outstanding, period not labelled, at 2026-07-29382,055,609 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338107.Report this figure at Jul 29, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.